SANGINITA.NS up 38.17% pre-market to INR 14.66: top gainer insight 11 Feb 2026

SANGINITA.NS stock jumps 38.17% in pre-market trade on 11 Feb 2026, trading at INR 14.66 on the NSE in India. The move follows heavy buying volume of 1,151,290.00 shares, nearly 21 times the average volume. Sanginita Chemicals Limited (SANGINITA.NS) leads top-gainer lists in the Basic Materials sector today. We examine what drove the spike, the valuation backdrop, technical signals, and what analysts and Meyka AI models see next.

Price action and volume: SANGINITA.NS stock pre-market move

SANGINITA.NS stock opened at INR 14.00 and hit a pre-market high of INR 14.99 on heavy participation. The jump from yesterday’s close of INR 10.61 is INR 4.05 or 38.17%, a one-day surge that pushed price above the 50-day average of INR 10.59.

Volume is the standout. Today’s 1,151,290.00 shares far exceed the average volume of 54,119.00, confirming conviction behind the rally and placing Sanginita among NSE top gainers in the Basic Materials sector.

Fundamentals and valuation: SANGINITA.NS stock view

Sanginita Chemicals Limited shows a market cap of INR 329,726,732.00 and a book value per share of INR 21.46. Trailing EPS is -1.31 and P/E is -9.72, reflecting last twelve months losses.

Valuation metrics include a low P/S of 0.18 and P/B of 0.59, which implies the market values assets conservatively. Debt-to-equity stands at 0.47, and current ratio is 1.95, indicating manageable short-term liquidity.

Technicals and momentum: SANGINITA.NS stock signals

Technical indicators show strong momentum for SANGINITA.NS stock. RSI is 72.74, marked overbought territory, while MACD histogram is positive at 0.15, supporting short-term bullishness.

Momentum risks exist. CCI at 243.84 and MFI at 85.59 warn of an overbought market. Traders should watch support near INR 10.17 (50-day middle band) and the intraday low INR 13.17.

Meyka AI rates and forecast: SANGINITA.NS stock grade and models

Meyka AI rates SANGINITA.NS with a score of 60.14 out of 100 (Grade B, HOLD). This grade factors S&P 500 comparison, sector and industry performance, financial growth, key metrics, forecasts, and analyst consensus. These grades are not guaranteed and we are not financial advisors.

Meyka AI’s forecast model projects a monthly price of INR 8.91, implying an -39.21% difference versus the current INR 14.66. Forecasts are model-based projections and not guarantees. Company rating dated 2026-02-09 carries a C / Sell recommendation in third-party data.

Catalysts and risks affecting SANGINITA.NS stock

Near-term catalysts include the upcoming earnings announcement on 2026-02-16 and any commentary on export demand for copper chemicals. Positive earnings or order wins could sustain momentum.

Risks are tangible: negative trailing EPS, weak profitability margins, and small free cash flow. Sector pressure in Basic Materials and overbought technicals can trigger sharp pullbacks.

Trading strategy and analyst view for SANGINITA.NS stock

For traders, consider booking partial profits on strength and use intraday support levels for scaling back in. Volatility suggests tight stops; a breakout above INR 15.00 with volume could signal continuation.

Analyst consensus is mixed. Use position sizing to limit downside and monitor the earnings report on 16 Feb 2026 before increasing exposure. Meyka AI provides this as data-driven market context.

Final Thoughts

SANGINITA.NS stock leads pre-market top gainers on 11 Feb 2026 after a 38.17% surge to INR 14.66 and unusually high volume of 1,151,290.00 shares. The rally reflects heavy buying but sits against weak trailing profitability and a negative EPS of -1.31. Technicals show overbought conditions with RSI 72.74, increasing the risk of a short-term pullback. Meyka AI rates the stock 60.14/100 (B, HOLD) and flags a model monthly projection of INR 8.91, implying -39.21% from the current price; forecasts are model-based projections and not guarantees. Key near-term drivers are the earnings release on 2026-02-16 and any company updates on export demand or large orders. Traders should weigh strong momentum against valuation and liquidity metrics, keep tight stops, and treat today’s move as an opportunity to reassess exposure rather than a clear buy signal. For company details visit Sanginita Chemicals website and see our platform data at Meyka stock page.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.